Release Date: 29/04/16 11:39 Summary: Appendix 4C - quarterly-TNT.AX Price Sensitive: Yes Download Document 703.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%